A strategic transaction strengthening its position across the pharmaceutical and chemical pharmaceutical supply chain
OLD PHARMA International S.r.l., a company of the Prodotti Gianni S.r.l. Group, announces the acquisition of Actim S.r.l., further strengthening its role as an integrated partner within the pharmaceutical and chemical‑pharmaceutical value chain.
This transaction is part of a focused and coherent growth strategy aimed at consolidating the Group’s presence across multiple stages of the supply chain, integrating specialized expertise, commercial capabilities and high value regulatory know how.
Through this acquisition, OLD PHARMA International reaffirms a development strategy based on integration, specialization and value creation, reinforcing its role as a reliable partner for the pharmaceutical industry.

Actim joins OLD PHARMA: enhancing chemical pharmaceutical specialization
The acquisition of Actim S.r.l. by OLD PHARMA expands and strengthens the overall offering through complementary and highly specialized expertise.
A dynamic player in the chemical pharmaceutical landscape
Actim is recognized for its ability to:
- identify and distribute hard‑to‑source intermediates, reagents and specialty chemicals;
- operate with high value‑added products;
- support customers in the development of technical solutions in the chemical‑pharmaceutical field, both nationally and internationally.
Joining OLD PHARMA enables Actim to evolve within a larger organizational structure, while preserving its identity and sharing its know how.
An acquisition focused on synergies and integrated growth
A tangible strengthening across the supply chain.
The transaction stems from a shared strategic vision and a common objective: to offer the market a broader, stronger and more integrated platform.
Specifically, the acquisition will make it possible to:
- develop operational synergies between the two companies;
- integrate technical, commercial and regulatory expertise;
- optimize logistics and organizational processes;
- expand the product and service portfolio for the pharmaceutical sector.
Strengthening the Group’s presence along the chemical pharmaceutical value chain will enable a more effective response to the demands of an ever evolving market.
Statements
Tiziano Maggi, Managing Director of Actim S.r.l.
“We are delighted to become part of OLD PHARMA International. This transaction represents a significant step in Actim’s evolution and will allow us to further enhance our ability to support customers and partners with even more comprehensive and competitive solutions.”
Stefano Gianni, Sole Director of OLD PHARMA International and Chairman of Prodotti Gianni S.r.l.
“The acquisition of Actim represents an important milestone in OLD PHARMA’s growth journey. We share values, vision and a strong commitment to quality and service: together, we will further strengthen our positioning within the pharmaceutical and chemical‑pharmaceutical supply chain.”
OLD PHARMA International: a qualified partner for the pharmaceutical sector
Part of the Prodotti Gianni Group since 2013, OLD PHARMA International operates as a distributor of chemical substances for the pharmaceutical market, with a specific focus on Active Pharmaceutical Ingredients (APIs), intermediates and specialty chemicals.
Quality, compliance and regulatory expertise
OLD PHARMA stands out for an operating model built on:
- high quality standards, in compliance with GMP regulations;
- solid and structured regulatory expertise;
- a rigorous quality system supporting pharmaceutical industry customers.
Thanks to a carefully selected international network, the company ensures traceability, compliance and reliability throughout the entire supply chain, positioning itself as a trusted partner in highly regulated environments.

